FIDSON Stock Overview
Manufactures and distributes pharmaceutical products in Nigeria. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 3/6 |
Fidson Healthcare Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦14.50 |
| 52 Week High | ₦19.20 |
| 52 Week Low | ₦12.40 |
| Beta | 0.21 |
| 11 Month Change | -7.94% |
| 3 Month Change | 5.45% |
| 1 Year Change | -7.05% |
| 33 Year Change | 157.26% |
| 5 Year Change | 325.33% |
| Change since IPO | 406.35% |
Recent News & Updates
Recent updates
Shareholder Returns
| FIDSON | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | -3.0% | -1.0% | 0.9% |
| 1Y | -7.1% | 0.8% | 54.4% |
Return vs Industry: FIDSON underperformed the NG Pharmaceuticals industry which returned 2% over the past year.
Return vs Market: FIDSON underperformed the NG Market which returned 53.6% over the past year.
Price Volatility
| FIDSON volatility | |
|---|---|
| FIDSON Average Weekly Movement | 7.2% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in NG Market | 9.2% |
| 10% least volatile stocks in NG Market | 3.2% |
Stable Share Price: FIDSON has not had significant price volatility in the past 3 months compared to the NG market.
Volatility Over Time: FIDSON's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 650 | Fidelis Ayebae | fidson.com |
Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables.
Fidson Healthcare Plc Fundamentals Summary
| FIDSON fundamental statistics | |
|---|---|
| Market cap | ₦33.28b |
| Earnings (TTM) | ₦3.48b |
| Revenue (TTM) | ₦72.41b |
9.6x
P/E Ratio0.5x
P/S RatioIs FIDSON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FIDSON income statement (TTM) | |
|---|---|
| Revenue | ₦72.41b |
| Cost of Revenue | ₦42.88b |
| Gross Profit | ₦29.52b |
| Other Expenses | ₦26.05b |
| Earnings | ₦3.48b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.52 |
| Gross Margin | 40.77% |
| Net Profit Margin | 4.80% |
| Debt/Equity Ratio | 154.8% |
How did FIDSON perform over the long term?
See historical performance and comparison